{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:27:19Z","timestamp":1789770439759,"version":"4.0.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","jacr.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Radiology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jacr.2017.02.026","type":"journal-article","created":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T09:32:12Z","timestamp":1493631132000},"page":"S245-S257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"S","title":["ACR Appropriateness Criteria \u00ae Prostate Cancer\u2014Pretreatment Detection, Surveillance, and\u00a0Staging"],"prefix":"10.1016","volume":"14","author":[{"given":"Fergus V.","family":"Coakley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aytekin","family":"Oto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren F.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam T.","family":"Froemming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat F.","family":"Fulgham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyanoosh","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Anik","family":"Sahni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy N.","family":"Showalter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aradhana M.","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhna","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn L.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick M.","family":"Remer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Eberhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacr.2017.02.026_bib1","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1001\/archinternmed.2010.262","article-title":"Impact of biochemical recurrence in prostate cancer among US veterans","volume":"170","author":"Uchio","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacr.2017.02.026_bib2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jacr.2017.02.026_bib3","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/j.1464-410X.2011.10365.x","article-title":"The economic burden of prostate cancer","volume":"108","author":"Roehrborn","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2017.02.026_bib4","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1097\/PAS.0b013e31817fb3a0","article-title":"Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens","volume":"32","author":"Evans","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jacr.2017.02.026_bib5","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s00428-006-0254-x","article-title":"Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911)","volume":"449","author":"van der Kwast","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jacr.2017.02.026_bib6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2214\/AJR.06.0401","article-title":"Per-sextant localization and staging of prostate cancer: correlation of imaging findings with whole-mount step section histopathology","volume":"188","author":"Graser","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2017.02.026_bib7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D\u2019Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jacr.2017.02.026_bib8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1464-410X.2012.11324.x","article-title":"An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011","volume":"111","author":"Eifler","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2017.02.026_bib9","first-page":"898","article-title":"External validation of the updated Partin tables in a cohort of North American men","volume":"180","author":"Karakiewicz","year":"2008","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib10","first-page":"105","article-title":"Validation of the Partin nomogram for prostate cancer in a national sample","volume":"183","author":"Yu","year":"2010","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1464-410X.2005.05713.x","article-title":"Is it necessary to separate clinical stage T1c from T2 prostate adenocarcinoma?","volume":"96","author":"Armatys","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2017.02.026_bib12","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/cncr.29147","article-title":"Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?","volume":"121","author":"Klaassen","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.jacr.2017.02.026_bib13","first-page":"114","article-title":"Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease","volume":"184","author":"Reese","year":"2010","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/cncr.25596","article-title":"Inaccuracies in assignment of clinical stage for localized prostate cancer","volume":"117","author":"Reese","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.jacr.2017.02.026_bib15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/jnci\/djj190","article-title":"Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy","volume":"98","author":"Stephenson","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jacr.2017.02.026_bib16","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.ijrobp.2007.08.021","article-title":"Percentage of biopsy cores positive for malignancy and biochemical failure following prostate cancer radiotherapy in 3,264 men: statistical significance without predictive performance","volume":"70","author":"Williams","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jacr.2017.02.026_bib17","first-page":"211","article-title":"Novel biomarkers and genomic tests in prostate cancer: a critical analysis","volume":"67","author":"Falzarano","year":"2015","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.jacr.2017.02.026_bib18","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.eururo.2014.05.004","article-title":"A\u00a017-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling","volume":"66","author":"Klein","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib19","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2741\/4391","article-title":"Next generation biomarkers in prostate cancer","volume":"21","author":"Locke","year":"2016","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.jacr.2017.02.026_bib20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/pcan.2015.31","article-title":"Which, when and why? Rational use of tissue-based molecular testing in localized prostate cancer","volume":"19","author":"Ross","year":"2016","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.jacr.2017.02.026_bib21","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacr.2017.02.026_bib22","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","article-title":"Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up","volume":"384","author":"Schroder","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacr.2017.02.026_bib23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.eururo.2013.05.059","article-title":"Magnetic resonance imaging\/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy","volume":"64","author":"Siddiqui","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nrurol.2013.179","article-title":"Prostate cancer: MRI\/US-guided biopsy\u2014a viable alternative to TRUS-guidance","volume":"10","author":"van de Ven","year":"2013","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.eururo.2012.06.004","article-title":"Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review","volume":"63","author":"Moore","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.eururo.2014.11.037","article-title":"Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis","volume":"68","author":"Schoots","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrurol.2015.242","article-title":"Imaging and evaluation of patients with high-risk prostate cancer","volume":"12","author":"Bjurlin","year":"2015","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib28","unstructured":"NCCN Clinical Practice Guidelines in Oncology. Prostate Cancer. Version 2.2016. 2016; Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf."},{"key":"10.1016\/j.jacr.2017.02.026_bib29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/MOU.0b013e3283548154","article-title":"Current status of transrectal ultrasound techniques in prostate cancer","volume":"22","author":"Smeenge","year":"2012","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib30","first-page":"512","article-title":"Contemporary impact of transrectal ultrasound lesions for prostate cancer detection","volume":"172","author":"Onur","year":"2004","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib31","first-page":"464","article-title":"Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score","volume":"178","author":"Mitterberger","year":"2007","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1464-410X.2007.06845.x","article-title":"The value of three-dimensional transrectal ultrasonography in staging prostate cancer","volume":"100","author":"Mitterberger","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2017.02.026_bib33","first-page":"71","article-title":"Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate","volume":"142","author":"Hodge","year":"1989","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib34","doi-asserted-by":"publisher","first-page":"386207","DOI":"10.1155\/2011\/386207","article-title":"Beyond diagnosis: evolving prostate biopsy in the era of focal therapy","volume":"2011","author":"Dominguez-Escrig","year":"2011","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.jacr.2017.02.026_bib35","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1111\/j.1464-410X.2008.08255.x","article-title":"Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study","volume":"103","author":"Kvale","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2017.02.026_bib36","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1200\/JCO.2010.33.0134","article-title":"Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance","volume":"29","author":"Porten","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jacr.2017.02.026_bib37","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJM199009063231001","article-title":"Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial","volume":"323","author":"Rifkin","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacr.2017.02.026_bib38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1148\/radiology.192.1.8208963","article-title":"Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques","volume":"192","author":"Tempany","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2017.02.026_bib39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1148\/radiol.2511080409","article-title":"Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy\u2014results of ACRIN prospective multi-institutional clinicopathologic study","volume":"251","author":"Weinreb","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2017.02.026_bib40","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1148\/radiol.2291020200","article-title":"Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging","volume":"229","author":"Engelbrecht","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2017.02.026_bib41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/01.rct.0000185384.27765.09","article-title":"Localization of prostate cancer using 3T MRI: comparison of T2-weighted and dynamic contrast-enhanced imaging","volume":"30","author":"Kim","year":"2006","journal-title":"J\u00a0Comput Assist Tomogr"},{"key":"10.1016\/j.jacr.2017.02.026_bib42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/0284185113494978","article-title":"Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T","volume":"55","author":"Li","year":"2014","journal-title":"Acta Radiol"},{"key":"10.1016\/j.jacr.2017.02.026_bib43","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/jmri.24317","article-title":"Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology","volume":"39","author":"Turkbey","year":"2014","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.jacr.2017.02.026_bib44","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1148\/radiol.11102066","article-title":"Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness","volume":"259","author":"Vargas","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2017.02.026_bib45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.eururo.2015.07.029","article-title":"Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis","volume":"70","author":"de Rooij","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib46","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.2214\/AJR.12.8510","article-title":"Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management","volume":"198","author":"Verma","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2017.02.026_bib47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS Prostate Imaging\u2014Reporting and Data System: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib48","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.clinimag.2016.01.011","article-title":"Endorectal multiparametric MRI of the prostate: incremental effect of perfusion imaging on biopsy target identification","volume":"40","author":"Romero","year":"2016","journal-title":"Clin Imaging"},{"key":"10.1016\/j.jacr.2017.02.026_bib49","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrclinonc.2015.70","article-title":"Prostate cancer: MR-TRUS fusion biopsy\u2014defining a new standard","volume":"12","author":"Klein","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jacr.2017.02.026_bib50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2214\/AJR.14.12681","article-title":"Evaluation of MRI-TRUS fusion versus cognitive registration accuracy for MRI-targeted, TRUS-guided prostate biopsy","volume":"204","author":"Cool","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2017.02.026_bib51","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.urolonc.2015.06.012","article-title":"Visually directed vs. software-based targeted biopsy compared to transperineal template mapping biopsy in the detection of clinically significant prostate cancer","volume":"33","author":"Valerio","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jacr.2017.02.026_bib52","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.eururo.2013.10.048","article-title":"A\u00a0prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial","volume":"66","author":"Wysock","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib53","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.eururo.2012.01.047","article-title":"Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers","volume":"62","author":"Hoeks","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib54","first-page":"1601","article-title":"Magnetic resonance imaging-ultrasound fusion targeted prostate biopsy in a consecutive cohort of men with no previous biopsy: reduction of over detection through improved risk stratification","volume":"194","author":"Mendhiratta","year":"2015","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib55","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.urology.2015.07.001","article-title":"Targeted prostate biopsy: lessons learned midst the evolution of a disruptive technology","volume":"86","author":"Nassiri","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2017.02.026_bib56","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ejrad.2015.10.013","article-title":"Prostate cancer on computed tomography: a direct comparison with multi-parametric magnetic resonance imaging and tissue pathology","volume":"85","author":"Jia","year":"2016","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jacr.2017.02.026_bib57","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.crad.2007.05.022","article-title":"The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis","volume":"63","author":"Hovels","year":"2008","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jacr.2017.02.026_bib58","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.eururo.2011.11.008","article-title":"Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib59","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00345-015-1669-2","article-title":"Is there still a role for computed tomography and bone scintigraphy in prostate cancer staging? An analysis from the EUREKA-1 database","volume":"34","author":"Gabriele","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib60","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","article-title":"EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013","volume":"65","author":"Heidenreich","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib61","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00256-014-1903-9","article-title":"Comparison of choline-PET\/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis","volume":"43","author":"Shen","year":"2014","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.jacr.2017.02.026_bib62","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/jncimonographs\/lgs031","article-title":"Overdiagnosis of prostate cancer","volume":"2012","author":"Sandhu","year":"2012","journal-title":"J\u00a0Natl Cancer Inst Monogr"},{"key":"10.1016\/j.jacr.2017.02.026_bib63","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.eururo.2014.03.002","article-title":"Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies","volume":"66","author":"Pokorny","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib64","first-page":"1571","article-title":"Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values","volume":"151","author":"Keetch","year":"1994","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib65","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/j.1464-410X.2012.11607.x","article-title":"Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial","volume":"111","author":"Ploussard","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2017.02.026_bib66","first-page":"2435","article-title":"Serial biopsy results in prostate cancer screening study","volume":"167","author":"Roehl","year":"2002","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib67","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.canep.2013.08.015","article-title":"When less is more: a simple predictive model for repeated prostate biopsy outcomes","volume":"37","author":"Vencalek","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.jacr.2017.02.026_bib68","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/j.1464-410X.2012.10958.x","article-title":"When serial prostate biopsy is recommended: most cancers detected are clinically insignificant","volume":"110","author":"Zaytoun","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2017.02.026_bib69","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.eururo.2013.03.025","article-title":"Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen","volume":"65","author":"Sonn","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib70","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.eururo.2015.06.005","article-title":"Relationship between prebiopsy multiparametric magnetic resonance imaging (MRI), biopsy indication, and MRI-ultrasound fusion-targeted prostate biopsy outcomes","volume":"69","author":"Meng","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib71","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.clinimag.2011.11.028","article-title":"Local staging of prostate cancer: comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound","volume":"36","author":"Jung","year":"2012","journal-title":"Clin Imaging"},{"key":"10.1016\/j.jacr.2017.02.026_bib72","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.eururo.2015.06.012","article-title":"Compliance rates with the Prostate Cancer Research International Active Surveillance (PRIAS) protocol and disease reclassification in noncompliers","volume":"68","author":"Bokhorst","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib73","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/pcan.2015.20","article-title":"Magnetic resonance imaging on disease reclassification among active surveillance candidates with low-risk prostate cancer: a diagnostic meta-analysis","volume":"18","author":"Guo","year":"2015","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.jacr.2017.02.026_bib74","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.urology.2014.09.060","article-title":"Multiparametric magnetic resonance imaging enhances detection of significant tumor in patients on active surveillance for prostate cancer","volume":"85","author":"Abdi","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2017.02.026_bib75","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/jmri.24710","article-title":"A\u00a0prospective comparison of MRI-US fused targeted biopsy versus systematic ultrasound-guided biopsy for detecting clinically significant prostate cancer in patients on active surveillance","volume":"41","author":"Da Rosa","year":"2015","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.jacr.2017.02.026_bib76","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1148\/radiol.10091147","article-title":"Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging","volume":"256","author":"Fradet","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2017.02.026_bib77","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/bju.12423","article-title":"Role of multiparametric 3.0-Tesla magnetic resonance imaging in patients with prostate cancer eligible for active surveillance","volume":"113","author":"Park","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.jacr.2017.02.026_bib78","first-page":"1247","article-title":"Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study","volume":"187","author":"Margel","year":"2012","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib79","first-page":"385","article-title":"Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply?","volume":"192","author":"Hu","year":"2014","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib80","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.eururo.2014.10.050","article-title":"Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review","volume":"67","author":"Schoots","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib81","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1200\/JCO.2010.31.4252","article-title":"Outcomes of active surveillance for men with intermediate-risk prostate cancer","volume":"29","author":"Cooperberg","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jacr.2017.02.026_bib82","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jamaoncol.2014.284","article-title":"Risk group and death from prostate cancer: implications for active surveillance in men with favorable intermediate-risk prostate cancer","volume":"1","author":"Raldow","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jacr.2017.02.026_bib83","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.radonc.2013.12.003","article-title":"Role of endorectal MR imaging and MR spectroscopic imaging in defining treatable intraprostatic tumor foci in prostate cancer: quantitative analysis of imaging contour compared to whole-mount histopathology","volume":"110","author":"Anwar","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jacr.2017.02.026_bib84","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1002\/cncr.20319","article-title":"The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy","volume":"100","author":"Hricak","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.jacr.2017.02.026_bib85","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.2214\/AJR.11.6425","article-title":"Endorectal MRI of prostate cancer: incremental prognostic importance of gross locally advanced disease","volume":"197","author":"Muglia","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2017.02.026_bib86","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00345-012-0826-0","article-title":"Accuracy of preoperative endorectal MRI in predicting extracapsular extension and influence on neurovascular bundle sparing in radical prostatectomy","volume":"31","author":"Roethke","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib87","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.urology.2014.06.010","article-title":"Toward better use of bone scans among men with early-stage prostate cancer","volume":"84","author":"Merdan","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2017.02.026_bib88","series-title":"AJCC cancer staging manual","author":"Edge","year":"2010"},{"key":"10.1016\/j.jacr.2017.02.026_bib89","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S0090-4295(96)80016-1","article-title":"Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer","volume":"47","author":"Gleave","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.jacr.2017.02.026_bib90","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/jjco\/hym097","article-title":"Bone scanning\u2014who needs it among patients with newly diagnosed prostate cancer?","volume":"37","author":"Hirobe","year":"2007","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.jacr.2017.02.026_bib91","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.ijrobp.2007.01.039","article-title":"Perineural invasion is a marker for pathologically advanced disease in localized prostate cancer","volume":"68","author":"Lee","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jacr.2017.02.026_bib92","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1089\/end.2007.0129","article-title":"Risk stratification for positive lymph nodes in prostate cancer","volume":"22","author":"Pettus","year":"2008","journal-title":"J\u00a0Endourol"},{"key":"10.1016\/j.jacr.2017.02.026_bib93","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1590\/S1677-55382003000200005","article-title":"Value of prostate specific antigen in predicting the existence of bone metastasis in scintigraphy","volume":"29","author":"Rhoden","year":"2003","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.jacr.2017.02.026_bib94","unstructured":"American College of Radiology. ACR Appropriateness Criteria\u00ae Radiation Dose Assessment Introduction. Available at: http:\/\/www.acr.org\/\u223c\/media\/ACR\/Documents\/AppCriteria\/RadiationDoseAssessmentIntro.pdf. Accessed May 1, 2016."}],"container-title":["Journal of the American College of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144017302065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144017302065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T06:30:02Z","timestamp":1535869802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1546144017302065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1546144017302065"],"URL":"https:\/\/doi.org\/10.1016\/j.jacr.2017.02.026","relation":{},"ISSN":["1546-1440"],"issn-type":[{"value":"1546-1440","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACR Appropriateness Criteria\u00ae Prostate Cancer\u2014Pretreatment Detection, Surveillance, and\u00a0Staging","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacr.2017.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American College of Radiology","name":"copyright","label":"Copyright"}]}}